These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2551101)

  • 1. Prophylactic activity against Sendai virus infection and macrophage activation with lipophilic derivatives of N-acetylglucosaminylmuramyl tri- or tetrapeptides.
    Iida J; Saiki I; Ishihara C; Azuma I
    Vaccine; 1989 Jun; 7(3):225-8. PubMed ID: 2551101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of tumoricidal macrophages and production of cytokines by synthetic muramyl dipeptide analogues.
    Saiki I; Saito S; Fujita C; Ishida H; Iida J; Murata J; Hasegawa A; Azuma I
    Vaccine; 1988 Jun; 6(3):238-44. PubMed ID: 2844032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the immune response by a synthetic adjuvant and analogs.
    Chedid L; Audibert F; Lefrancier P; Choay J; Lederer E
    Proc Natl Acad Sci U S A; 1976 Jul; 73(7):2472-5. PubMed ID: 1065901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective activity of recombinant cytokines against Sendai virus and herpes simplex virus (HSV) infections in mice.
    Iida J; Saiki I; Ishihara C; Azuma I
    Vaccine; 1989 Jun; 7(3):229-33. PubMed ID: 2476892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the synthetic lipid A-related compound, DT-5461, on resistance to Sendai virus infection in mice.
    Yoshida R; Sato K; Yoo YC; Yoshimatsu K; Tamura M; Ishihara C; Arikawa J; Azuma I
    Immunopharmacology; 1994; 28(2):153-61. PubMed ID: 8002289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage activation and host augmentation against Sendai or herpes simplex virus (HSV) infections with synthetic polypeptides in mice.
    Iida J; Nishi N; Saiki I; Mizukoshi N; Ishihara C; Tokura S; Azuma I
    Int J Immunopharmacol; 1989; 11(3):249-58. PubMed ID: 2544534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The generation of 'cytotoxic' macrophages in mice during infection with influenza A or Sendai virus.
    Mak NK; Leung KN; Ada GL
    Scand J Immunol; 1982 Jun; 15(6):553-61. PubMed ID: 6181555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection.
    Belosevic M; Davis CE; Meltzer MS; Nacy CA
    J Immunol; 1988 Aug; 141(3):890-6. PubMed ID: 3135315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of host-defense mechanism with synthetic adjuvants and recombinant cytokines against viral infection in mice.
    Azuma I; Ishihara C; Iida J; Yoo YC; Yoshimatsu K; Arikawa J
    Adv Exp Med Biol; 1992; 319():253-63. PubMed ID: 1329443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined oral/nasal immunization protects mice from Sendai virus infection.
    Nedrud JG; Liang XP; Hague N; Lamm ME
    J Immunol; 1987 Nov; 139(10):3484-92. PubMed ID: 2824609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of muramyl dipeptide and its stearoyl derivatives on resistance to Sendai virus infection in mice.
    Ishihara C; Hamada N; Yamamoto K; Iida J; Azuma I; Yamamura Y
    Vaccine; 1985 Dec; 3(5):370-4. PubMed ID: 2417426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral immunization against respiratory viruses in mice.
    Nedrud J; Sigmund N; Brunschwig E; Lamm M
    Adv Exp Med Biol; 1995; 371B():1595-8. PubMed ID: 7502863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human parainfluenza virus type 1 immunization of infant mice protects from subsequent Sendai virus infection.
    Sangster M; Smith FS; Coleclough C; Hurwitz JL
    Virology; 1995 Sep; 212(1):13-9. PubMed ID: 7676623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of Sendai virus growth by treatment with N alpha-acetylmuramyl-L-alanyl-D-isoglutaminyl-N epsilon-stearoyl-L-lysine in mice.
    Ishihara C; Mizukoshi N; Iida J; Kato K; Yamamoto K; Azuma I
    Vaccine; 1987 Dec; 5(4):295-301. PubMed ID: 2448969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide.
    Kast WM; Roux L; Curren J; Blom HJ; Voordouw AC; Meloen RH; Kolakofsky D; Melief CJ
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2283-7. PubMed ID: 1848698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Entamoeba histolytica extract and interferon-gamma activation of macrophage-mediated amoebicidal function.
    Ghadirian E; Denis M
    Immunobiology; 1992 Jun; 185(1):1-10. PubMed ID: 1398736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction and expression of respiratory IgA immunity against Sendai virus in mice.
    Nedrud JG; Mazanec MB; Liang X; Hague N; Lamm ME
    Adv Exp Med Biol; 1987; 216B():1847-54. PubMed ID: 2827447
    [No Abstract]   [Full Text] [Related]  

  • 18. Interleukin-2 suppresses activated macrophage intracellular killing activity by inducing macrophages to secrete TGF-beta.
    Nelson BJ; Danielpour D; Rossio JL; Turpin J; Nacy CA
    J Leukoc Biol; 1994 Jan; 55(1):81-90. PubMed ID: 8283143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of non-specific host resistance against Sendai virus and Escherichia coli infections by chitin derivatives in mice.
    Iida J; Une T; Ishihara C; Nishimura K; Tokura S; Mizukoshi N; Azuma I
    Vaccine; 1987 Dec; 5(4):270-4. PubMed ID: 2829455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic activity of dihydroheptaprenol, a synthetic polyprenol derivative, against Sendai virus infection in mice.
    Iida J; Ishihara C; Mizukoshi N; Kitoh K; Tsukidate K; Katsu K; Toyosawa T; Azuma I
    Vaccine; 1990 Aug; 8(4):376-80. PubMed ID: 1697723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.